As of 2026-02-09, the Relative Valuation of Epizyme Inc (EPZM) is (14.90) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.47 USD, the upside of Epizyme Inc based on Relative Valuation is -1113.7%.
The range of the Relative Valuation is (10.44) - (19.25) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.4x - 15.6x | 12.0x |
| Forward P/E multiples | 8.5x - 15.8x | 12.2x |
| Fair Price | (10.44) - (19.25) | (14.90) |
| Upside | -810.2% - -1409.7% | -1113.7% |
| Date | P/E |